Harvard Women's Health Watch

Shunning osteoporosis treatment isn’t a wise decision for most women

Some women are forgoing bisphosphonate treatment to prevent osteoporotic fractures because they fear developing rare side effects. Forgoing drugs that slow bone loss to avoid rare side effects can be the wrong decision for your hips and spine. A front-page article in the June 1, 2016, edition of The New York Times carried this headline: “Fearing drugs’ rare side effects, millions take their chances with osteoporosis.” The article described a situation all…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In